Original Article

You have full text access to this OnlineOpen article

Bone health in children and adolescents after allogeneic stem cell transplantation

High prevalence of vertebral compression fractures

  1. Mervi Taskinen MD1,†,*,
  2. Ulla M. Saarinen-Pihkala MD1,
  3. Liisa Hovi MD1,
  4. Kim Vettenranta MD1,
  5. Outi Mäkitie MD2

Article first published online: 4 JUN 2007

DOI: 10.1002/cncr.22796

Issue

Cancer

Cancer

Volume 110, Issue 2, pages 442–451, 15 July 2007

Additional Information

How to Cite

Taskinen, M., Saarinen-Pihkala, U. M., Hovi, L., Vettenranta, K. and Mäkitie, O. (2007), Bone health in children and adolescents after allogeneic stem cell transplantation. Cancer, 110: 442–451. doi: 10.1002/cncr.22796

Author Information

  1. 1

    Division of Hematology–Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland

  2. 2

    Division of Endocrinology and Metabolism, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland

  1. †

    Fax: (011) 358-9-47174707

*The Hospital for Children and Adolescents, University of Helsinki, P.O. Box 281, FIN-00029 Helsinki, Finland

Publication History

  1. Issue published online: 29 JUN 2007
  2. Article first published online: 4 JUN 2007
  3. Manuscript Accepted: 15 MAR 2007
  4. Manuscript Revised: 14 MAR 2007
  5. Manuscript Received: 24 JAN 2007

Funded by

  • Nona and Kullervo Väre Foundation
  • The Foundation for Pediatric Research
  • Päivikki and Sakari Sohlberg Foundation
  • Finnish Medical Society Duodecim
  • Research Funding of the Helsinki University Hospitals

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (155K)

REFERENCES

  • 1
    Sochett EB,Makitie O. Osteoporosis in chronically ill children. Ann Med. 2005; 37: 286–294.
  • 2
    Rodino MA,Shane E. Osteoporosis after organ transplantation. Am J Med. 1998; 104: 459–469.
  • 3
    Cohen A,Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporosis Int. 2003; 14: 617–630.
  • 4
    Valimaki MJ,Kinnunen K,Volin L, et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant. 1999; 23: 355–361.
  • 5
    Schulte C,Beelen DW,Schaefer UW,Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporosis Int. 2000; 11: 344–353.
  • 6
    Buchs N,Helg C,Collao C, et al. Allogneic bone marrow transplantation is associated with preferential femoral neck bone loss. Osteoporosis Int. 2001; 12: 880–886.
  • 7
    Taskinen M,Kananen K,Valimaki MJ, et al. Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood. Pediatr Transplant. 2006; 10: 90–97.
    Direct Link:
  • 8
    Lee WY,Cho SW,Oh ES, et al. The effect of bone marrow transplantation on the osteoblastic differentation of human bone marrow stromal cells. J Clin Endocrinol Metab. 2002; 87: 329–335.
  • 9
    Helenius I,Remes V,Salminen S, et al. Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res. 2006; 21: 380–387.
    Direct Link:
  • 10
    Kananen K,Volin L,Tahtela R,Laitinen K,Ruutu T,Valimaki MJ. Recovery of bone mass and normalization of bone turn-over in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002; 29: 33–39.
  • 11
    Nysom K,Holm K,Fleischer Michaelsen K, et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant. 2000; 25: 191–196.
  • 12
    Shulman HM,Sullivan KM,Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980; 69: 204–217.
  • 13
    Valta H,Lahdenne P,Jalanko H,Aalto K,Makitie O. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007; 34: 831–836.
  • 14
    Tanner JM. Growth and endocrinology of the adolescent. In: GardnerLI, editor. Endocrine and Genetic Diseases of Childhood. Philadelphia: W.B. Saunders Co.; 1969.
  • 15
    Sorva R,Lankinen S,Tolppanen EM,Perheentupa J. Variation of growth in height and weight of children. II. After infancy. Acta Paediatr Scand. 1990; 79: 498–506.
    Direct Link:
  • 16
    Greulich WW,Pyle SI. Radiographic Atlas of the Skeletal Development of the Hand and Wrist. 2nd ed. Palo Alto, CA: Stanford University Press; 1959.
  • 17
    Makitie O,Doria AS,Henriques F, et al. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr. 2005; 146: 395–401.
  • 18
    Bhatia S,Ramsay NKC,Weisdorf D,Griffiths H,Robison LL. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant. 1998; 22: 87–90
  • 19
    Daniels MW,Wilson DM,Paguntalan HG,Hoffman AR,Bachrach LK. Bone mineral density in pediatric transplant recipients. Transplantation. 2003; 76: 673–678.
  • 20
    Shane E,Rivas MC,Silverberg SJ,Kim TS,Staron RB,Bilezikian JP. Osteoporosis after cardiac transplantation. Am J Med. 1993; 94: 257–264.
  • 21
    Reddy SP,Junewick JJ,Backstrom JW. Distribution of spinal fractures in children: does age, mechanism of injury, or gender play a significant role? Pediatr Radiol. 2003; 33: 776–781.
  • 22
    Nevitt MC,Ross PD,Palermo L,Musliner T,Genant HK,Thompson DE. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures.The Fracture Intervention Trial Research Group. Bone. 1999; 25: 613–619.
  • 23
    Hans D,Fuerst T,Lang T, et al. How can we measure bone quality? Baillieres Clin Rheumatol. 1997; 1: 495–515.
  • 24
    Stern JM,Chesnut CH3rd,Bruemmer B, et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant. 1996; 17: 395–400.
  • 25
    Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res. 1996; 11: 1–7.
    Direct Link:
  • 26
    Jaksch M.Mattsson J. The pathophysiology of acute graft-versus-host disease. Scand J Immunol. 2005; 61: 398–409.
    Direct Link:
  • 27
    Manolagas SC,Jilka RL. Bone marrow, cytokines and bone remodelling. N Engl J Med. 1995; 332: 305–311.
  • 28
    Lee WY,Baek KH,Rhee EJ,Tae HJ, et al. Impact of circulating bone-resorbing cytokines on subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant. 2004; 34: 89–94.
  • 29
    Kaste SC,Shidler TJ,Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004; 33: 435–441.
  • 30
    Riggs BL,Khosla S,Melton LJIII. Sex steroids and the construction and conservation of the adult skeleton. Endocrine Rev. 2002; 23: 279–302.
  • 31
    Monson JP,Drake WM,Carroll PV,Weaver JU,Rodriguez-Arnao J,Savage MO. Influence of growth hormone on accretion of bone mass. Hormone Res. 2002; 58 ( suppl 1): 52–56.
  • 32
    Olney RC. Regulation of bone mass by growth hormone. Med Pediatr Oncol. 2003; 41: 228–234.
    Direct Link:
  • 33
    Kaufman JM,Taelman P,Vermeulen A,Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 1992; 74: 118–123.
  • 34
    Rubin LA,Hawker GA,Peltekova VD,Fielding LJ,Ridout R,Cole DE. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res. 1999; 14: 633–643.
    Direct Link:
  • 35
    Leonard MB,Propert KJ,Zemel BS,Stallings VA,Feldman HI. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr. 1999; 135: 182–188.
  • 36
    Kuczmarski RJ,Ogden CL,Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000; 314: 1–27.
  • 37
    Schulte CMS,Beelen DW. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood. 2004; 103: 3635–3643.
  • 38
    Kananen K,Volin L,Laitinen K,Alfthan H,Ruutu T,Valimaki MJ. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab. 2005; 90: 3877–3885.
  • 39
    Thornton J,Ashcroft DM,Muqhal MZ,Elliott RA,O'Neill TW,Symmons D. Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis. Arch Dis Child. 2006; 91: 753–761.
View Full Article (HTML) Get PDF (155K)